Hospital groups urged two federal appeals court to back the government in its fight to force Lilly and AstraZeneca to end restrictions on 340B pricing when covered entities use contract pharmacies.

Hospital Groups Cite Supreme Court Decision in Latest Briefs Backing Feds in Lilly and AstraZeneca 340B Cases

Five groups that represent 340B hospitals have filed briefs in two federal appeals courts backing the federal government in its fight to force drug manufacturers Eli Lilly and AstraZeneca to end restrictions on 340B drug discounts when covered entities use contract pharmacies.

American Hospital Association, 340B Health, America’s Essential Hospitals, Association of American Medical Colleges, and Children’s Hospital Association filed their joint amicus brief in the lawsuit over Lilly’s 340B policy on July 1. The case is before the U.S. Seventh Circuit Court of Appeals in Chicago.

Five groups that represent 340B hospitals have filed briefs in two federal appeals courts backing the federal government in its fight to force drug manufacturers Eli Lilly and AstraZeneca to end restrictions on 340B drug discounts when covered entities use contract pharmacies.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer